Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
5(23%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
36%
Ph phase_4
2
9%
Ph phase_2
1
5%
Ph phase_1
1
5%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

5

trials recruiting

Total Trials

22

all time

Status Distribution
Active(7)
Completed(10)
Terminated(1)
Other(4)

Detailed Status

Completed10
Recruiting5
unknown4
Not yet recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 42 (16.7%)
N/A8 (66.7%)

Trials by Status

completed1045%
unknown418%
withdrawn15%
recruiting523%
not_yet_recruiting29%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07562009Not Applicable

Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.

Not Yet Recruiting
NCT07501325Not Applicable

Recombinant Tropomyosin- and Hemocyanin-Specific IgE in Children With Suspected Shrimp Allergy

Not Yet Recruiting
NCT04239131Not Applicable

Prospective Study About Sensitization Pattern to Insects as Food Source in Patients With House Dust Mite Allergy

Completed
NCT06183398Not Applicable

Analysis of the Prevalence of Sensitization to Plants Containing Gibberellins Using Realistic Skin Prick Tests

Recruiting
NCT06518473

Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients

Recruiting
NCT05042830Not Applicable

Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact

Recruiting
NCT06156046

Tolerance in Beekeepers

Recruiting
NCT06237660

Longitudinal Preschool Wheeze Biomarker Study

Recruiting
NCT06257797

Fenugreek: an Emergent Allergen

Completed
NCT00290368Phase 2

Repeat Nasal Allergen Challenge

Completed
NCT05462444

Development of Personalized Balanced Nutrition Concept Through an IT Platform

Unknown
NCT05596656

IgE-mediated Allergies Among Type 1 Diabetes Mellitus Children, Single Centre Observational Study

Completed
NCT04958616

House Dust Mites Sensitization and Level of Asthma Control and Severity in Children

Completed
NCT04322838

Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?

Unknown
NCT00291408Phase 4

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

Withdrawn
NCT03820154Not Applicable

Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest

Unknown
NCT01567319Phase 1

Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts

Completed
NCT02764242Not Applicable

The Causative Insects in Severe Insect Sting Allergy

Completed
NCT02561390Not Applicable

Comparison Between spIgE and Skin Prick Test of Local and Imported Aeroallergens

Completed
NCT02332122

Detection of Aspergillus Fumigatus and Sensitization in COPD Patients With Bronchiectasis vs Without Bronchiectasis

Unknown

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
22